FMS News and Press, Fresenius Medical Care AG From 11/15/22

Summary Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, trusts, and offshore fu...

Fresenius Medical Care (NYSE: FMS) , Pfizer (NYSE: PFE) , and Viatris (NASDAQ: VTRS) have seen their shares slide so far this year. That may be bad news for their current investors, but it could be good news for the companies' future investors. I believe these ...

Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. US-China relations remain tense but so far don...

Summary International markets faced headwinds as slowing economic growth and hawkish monetary policy by central banks stoked investor fears of a possible global recession. The Strategy outperformed its benchmark, as high-quality stocks in the materials and industrials sectors over...

Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Executive Officer & Chair of the Management Board Helen Giza - De...

Fresenius Medical Care ( NYSE: FMS ) is under pressure to make changes after the company cut its 2022 financial outlook and it was disclosed activist investor Elliott Investment Management now has a 3% stake in the company, Bloomberg reported. The financial new...

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2022 Q3 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2022 Q3 - Results - Earnings Call Presentation

Fresenius Medical Care ( NYSE: FMS ) on Sunday cut its net income outlook for 2022 amid higher labor costs and slower than expected recovery in North America business. The German dialysis care provider's Q3 Basis EPS (excl. special items) declined -16.84% Y...

Summary Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breaking out of one of its most important short-term resistance. In this tec...

Fresenius Medical Care ( NYSE: FMS ) rose 3.1% in premarket trading on a report that activist Elliott Investment Management took a stake in Fresenius SE & Co. ( OTCPK:FSNUF ). Elliott is said to have taken a substantial position in Fresenius SE and may be looki...